Dr. Talha Riaz, M.D.
What this data tells you about Dr. Riaz
Dr. Talha Riaz is a hematology & oncology in Weatherford, TX, with 11 years in practice. Based on federal Medicare data, Dr. Riaz performed 195,234 Medicare services across 1,357 unique beneficiaries.
Between the years covered by Open Payments, Dr. Riaz received a total of $3,772 from 50 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riaz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 97,500 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells | 47,521 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 16,800 | $43 | $115 |
| Anti-nausea injection (fosaprepitant) | 16,050 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,100 | $19 | $40 |
| Dexamethasone injection (steroid) | 2,510 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,770 | $1 | $52 |
| Office visit, established patient, complex (40-54 min) | 587 | $132 | $350 |
| Office visit, established patient (30-39 min) | 487 | $89 | $275 |
| Injection, carboplatin, 50 mg | 436 | $2 | $60 |
| Injection, zoledronic acid, 1 mg | 389 | $7 | $300 |
| Flow cytometry, additional marker | 371 | $19 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 358 | $22 | $100 |
| Administration of chemotherapy into vein, 1 hour or less | 344 | $96 | $412 |
| Injection of additional new drug or substance into vein | 333 | $12 | $70 |
| Drug injection, under skin or into muscle | 268 | $11 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 261 | $47 | $190 |
| Administration of additional new drug or substance into vein, 1 hour or less | 168 | $48 | $202 |
| COVID-19 test, self-administered | 164 | $12 | $30 |
| Administration of chemotherapy into vein, each additional hour | 132 | $20 | $93 |
| Hospital follow-up visit, high complexity | 123 | $91 | $250 |
| Injection, diphenhydramine hcl, up to 50 mg | 113 | $1 | $10 |
| New patient office visit, complex (60-74 min) | 81 | $154 | $500 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 75 | $47 | $160 |
| Ct scan of chest with contrast | 48 | $46 | $401 |
| CT scan of abdomen and pelvis with contrast | 46 | $165 | $681 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $106 | $450 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 40 | $1,155 | $4,069 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 23 | $36 | $120 |
| Office visit, established patient (20-29 min) | 22 | $60 | $183 |
| Irrigation of implanted venous access drug delivery device | 20 | $17 | $69 |
| Initial hospital admission, high complexity | 20 | $133 | $500 |
| Advance care planning consultation, first 30 min | 17 | $60 | $250 |
| Flow cytometry technique for dna or cell analysis, first marker | 16 | $58 | $200 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Riaz is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Riaz experienced with iron infusion (injectafer)?
Does Dr. Riaz receive payments from pharmaceutical companies?
How do Dr. Riaz's costs compare to other hematology & oncologys in Weatherford?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology